Key result
Myocardin interacts with Smad3 to synergistically activate smooth muscle gene promoters independent of CArG boxes.
Answers are grounded in this paper and cite their sources.
Demonstrates that myocardin interacts directly with Smad3 to stimulate smooth muscle gene expression without CArG boxes, revealing a novel transforming growth factor-beta1 signaling pathway.
Transforming growth factor (TGF)-beta1 is an important cytokine involved in various diseases. However, the molecular mechanism whereby TGF-beta1 signaling modulates the regulatory network for smooth muscle gene transcription remains largely unknown. To address this question, we previously identified a Smad-binding element (SBE) in the SM22alpha promoter as one of the TGF-beta1 response elements. Here, we show that mutation of the SBE reduces the activation potential of a SM22alpha promoter in transgenic mice during embryogenesis. Chromatin immunoprecipitation assays reveal that TGF-beta1 induces Smad3 binding to the SM22alpha promoter in vivo. A multimerized SBE promoter responsive to TGF-beta1 signaling is highly activated by Smad3 but not by the closely related Smad2. Intriguingly, myocardin (Myocd), a known CArG box-dependent serum response factor coactivator, participates in Smad3-mediated TGF-beta1 signaling and synergistically stimulates Smad3-induced SBE promoter activity independent of the CArG box; no such synergy is seen with Smad2. Importantly, Myocd cooperates with Smad3 to activate the wild-type SM22alpha, SM myosin heavy chain, and SMalpha-actin promoters; they also activate the CArG box-mutated SM22alpha promoter as well as the CArG box-independent aortic carboxypeptidase-like protein promoter. Immunopreciptiation assays reveal that Myocd and Smad3 directly interact both in vitro and in vivo. Mutagenesis studies indicate that the C-terminal transactivation domains of Myocd and Smad3 are required for their functional synergy. These results reveal a novel regulatory mechanism whereby Myocd participates in TGF-beta1 signal pathway through direct interaction with Smad3, which binds to the SBEs. This is the first demonstration that Myocd can act as a transcriptional coactivator of the smooth muscle regulatory network in a CArG box-independent manner.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2005) studied Smooth muscle gene transcription / TGF-beta1 signaling. Myocardin (Myocd) and Smad3 vs. Smad2 or mutated SBE/CArG box promoters was evaluated on Activation of SM22alpha and other smooth muscle gene promoters. Myocardin directly interacts with Smad3 to synergistically stimulate TGF-beta1-induced SM22alpha and smooth muscle promoter activity in a CArG box-independent manner.
Synapse has enriched 10 related papers. Consider them for comparative context: